Loading...
Cardiovascular adverse events in the drug‐development program of bupropion for smoking cessation: A systematic retrospective adjudication effort
BACKGROUND: In 2011, the US Food and Drug Administration requested that GlaxoSmithKline perform retrospective adjudication of cardiovascular (CV) events reported in the bupropion drug‐development trials for smoking cessation. HYPOTHESIS: Retrospective adjudication of clinical trial data will not inc...
Na minha lista:
| Udgivet i: | Clin Cardiol |
|---|---|
| Main Authors: | , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Wiley Periodicals, Inc.
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6490529/ https://ncbi.nlm.nih.gov/pubmed/28605035 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/clc.22744 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|